Clinical trial
Valproate in Late Life Schizophrenia
NCT00194025 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00194025 |
|---|---|
| Title | Valproate in Late Life Schizophrenia |
| Official title | Add-on Valproate in Late Life Schizophrenia |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Valproate |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 6, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: